These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 38586095)

  • 1. Targeting super-enhancer activity for colorectal cancer therapy.
    Voutsadakis IA
    Am J Transl Res; 2024; 16(3):700-719. PubMed ID: 38586095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular understanding of super-enhancer dysregulation in cancer.
    Yoshino S; Suzuki HI
    Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets.
    Bacabac M; Xu W
    Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Super-enhancers in cancer.
    Thandapani P
    Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Super-enhancers and novel therapeutic targets in colorectal cancer.
    Liu Q; Guo L; Lou Z; Xiang X; Shao J
    Cell Death Dis; 2022 Mar; 13(3):228. PubMed ID: 35277481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor.
    Zhang J; Liu W; Zou C; Zhao Z; Lai Y; Shi Z; Xie X; Huang G; Wang Y; Zhang X; Fan Z; Su Q; Yin J; Shen J
    Clin Cancer Res; 2020 Jun; 26(11):2681-2692. PubMed ID: 31937612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The super-enhancer repertoire in porcine liver.
    Zhang Y; Zhang J; Wang C; Dai H; Du X; Li Q; Pan Z
    J Anim Sci; 2023 Jan; 101():. PubMed ID: 36800318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.
    Wang C; Jiang S; Zhang L; Li D; Liang J; Narita Y; Hou I; Zhong Q; Gewurz BE; Teng M; Zhao B
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology of super-enhancer reprogramming and activation in cancer.
    Zhou RW; Parsons RE
    Epigenetics Chromatin; 2023 Jul; 16(1):29. PubMed ID: 37415185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.
    Hah N; Benner C; Chong LW; Yu RT; Downes M; Evans RM
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):E297-302. PubMed ID: 25564661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes.
    Moorthy SD; Davidson S; Shchuka VM; Singh G; Malek-Gilani N; Langroudi L; Martchenko A; So V; Macpherson NN; Mitchell JA
    Genome Res; 2017 Feb; 27(2):246-258. PubMed ID: 27895109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Super-enhancers include classical enhancers and facilitators to fully activate gene expression.
    Blayney JW; Francis H; Rampasekova A; Camellato B; Mitchell L; Stolper R; Cornell L; Babbs C; Boeke JD; Higgs DR; Kassouf M
    Cell; 2023 Dec; 186(26):5826-5839.e18. PubMed ID: 38101409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus oncoprotein super-enhancers control B cell growth.
    Zhou H; Schmidt SC; Jiang S; Willox B; Bernhardt K; Liang J; Johannsen EC; Kharchenko P; Gewurz BE; Kieff E; Zhao B
    Cell Host Microbe; 2015 Feb; 17(2):205-16. PubMed ID: 25639793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer.
    Di Benedetto C; Oh J; Choudhery Z; Shi W; Valdes G; Betancur P
    BMC Cancer; 2022 Oct; 22(1):1056. PubMed ID: 36224576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer.
    Tang SC; Vijayakumar U; Zhang Y; Fullwood MJ
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Potential Pathogenic Super-Enhancers-Driven Genes in Pulmonary Fibrosis.
    Li H; Zhao C; Li Z; Yao K; Zhang J; Si W; Liu X; Jiang Y; Zhu M
    Front Genet; 2021; 12():644143. PubMed ID: 34054916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing.
    Yoo KH; Hennighausen L; Shin HY
    J Mammary Gland Biol Neoplasia; 2019 Mar; 24(1):47-59. PubMed ID: 30291498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of tumor oncogenes by disruption of super-enhancers.
    Lovén J; Hoke HA; Lin CY; Lau A; Orlando DA; Vakoc CR; Bradner JE; Lee TI; Young RA
    Cell; 2013 Apr; 153(2):320-34. PubMed ID: 23582323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Super-Enhancers for Disease Treatment and Diagnosis.
    Shin HY
    Mol Cells; 2018 Jun; 41(6):506-514. PubMed ID: 29754476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Transcription Factor ERG Regulates Super-Enhancers Associated With an Endothelial-Specific Gene Expression Program.
    Kalna V; Yang Y; Peghaire CR; Frudd K; Hannah R; Shah AV; Osuna Almagro L; Boyle JJ; Göttgens B; Ferrer J; Randi AM; Birdsey GM
    Circ Res; 2019 Apr; 124(9):1337-1349. PubMed ID: 30892142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.